Insider Shareholders with Direct Ownership of Neumora Therapeutics, Inc. (NMRA)
This section provides a comprehensive overview of the insiders with direct ownership of Neumora Therapeutics, Inc. (NMRA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Neumora Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 35,368,653 | 0 | 35,368,653 | 1 |
Sep 19, 2023
Added 4.75%
|
|
| 171,250 | 0 | 7,818,166 | 1 |
Feb 14, 2024
Added 2.14%
|
|
|
Henry O Gosebruch
President & CEO |
80,000 | 0 | 462,345 | 1 |
Feb 14, 2024
Added 14.75%
|
|
Carol Y. Suh
Chief Operating Officer |
85,000 | 0 | 374,674 | 1 |
Feb 14, 2024
Added 18.49%
|
|
Joshua Pinto
Chief Financial Officer |
85,000 | 0 | 323,965 | 1 |
Feb 14, 2024
Added 20.78%
|
|
Robert A. Lenz
Head of R&D |
402,941 | 88,235 | 314,706 | 7 |
Oct 10, 2024
Reduced 2.56%
|
|
Daljit Singh Aurora
Chief Strategy Officer |
97,500 | 114,703 | 97,500 | 2 |
Apr 22, 2024
Reduced 54.05%
|
| 47,717 | 0 | 47,717 | 3 |
Jun 13, 2024
Added 29.64%
|
|
| 20,625 | 0 | 24,448 | 1 |
Feb 14, 2024
Added 45.76%
|
|
| 41,888 | 21,788 | 20,100 | 5 |
Oct 18, 2024
Reduced 41.14%
|
|
| 20,100 | 0 | 20,100 | 1 |
Jun 13, 2024
Added 50.0%
|
|
| 20,100 | 0 | 20,100 | 1 |
Jun 13, 2024
Added 50.0%
|
|
| 20,100 | 0 | 20,100 | 1 |
Jun 13, 2024
Added 50.0%
|